Research output per year
Research output per year
Fingerprint
Dive into the research topics where Tapan Mahendra Kadia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Activity of venetoclax-based therapy in chronic myelomonocytic leukemia
Montalban-Bravo, G., Hammond, D., DiNardo, C. D., Konopleva, M., Borthakur, G., Short, N. J., Ramos-Perez, J., Guerra, V., Kanagal-Shamanna, R., Naqvi, K., Sasaki, K., Jabbour, E., Pemmaraju, N., Kadia, T. M., Ravandi, F., Daver, N., Estrov, Z., Pierce, S., Kantarjian, H. & Garcia-Manero, G., May 2021, In: Leukemia. 35, 5, p. 1494-1499 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach
Kantarjian, H. M., Kadia, T. M., DiNardo, C. D., Welch, M. A. & Ravandi, F., Apr 15 2021, In: Cancer. 127, 8, p. 1186-1207 22 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations -
Acute myeloid leukemia: current progress and future directions
Kantarjian, H., Kadia, T., DiNardo, C., Daver, N., Borthakur, G., Jabbour, E., Garcia-Manero, G., Konopleva, M. & Ravandi, F., Feb 2021, In: Blood cancer journal. 11, 2, 41.Research output: Contribution to journal › Review article › peer-review
Open Access13 Scopus citations -
An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Short, N. J., Konopleva, M., Kadia, T., Kebriaei, P., Daver, N., Huang, X., Masarova, L., Cook, R., Jain, N., Jabbour, E., Kantarjian, H. & Ravandi, F., Jul 1 2021, In: American journal of hematology. 96, 7, p. E229-E232Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia
Saxena, K., Herbrich, S. M., Pemmaraju, N., Kadia, T. M., DiNardo, C. D., Borthakur, G., Pierce, S. A., Jabbour, E., Wang, S. A., Bueso-Ramos, C., Loghavi, S., Tang, G., Cheung, C. M., Alexander, L., Kornblau, S., Andreeff, M., Garcia-Manero, G., Ravandi, F., Konopleva, M. Y. & Daver, N., Oct 15 2021, In: Cancer. 127, 20, p. 3761-3771 11 p.Research output: Contribution to journal › Article › peer-review